Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2002
In patients with malignant glioma, to determine the efficacy of prophylaxis with LMWH (dalteparin) compared to placebo, both commenced beyond the immediate postoperative period, for the prevention of VTE.
Epistemonikos ID: ec91765d1a8f5b89ae1bc3bf02ad61ea6b5e347a
First added on: Jun 07, 2022